Status:
UNKNOWN
The Safety and Adverse Reaction Study of Neonatal to Inhaled Carbon Monoxide
Lead Sponsor:
CAN WANG
Collaborating Sponsors:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Conditions:
Miscellaneous Disorders in the Fetus or Newborn
Eligibility:
All Genders
1-1 years
Phase:
NA
Brief Summary
Based on the study about carbon monoxide in human inflammatory and other beneficial physiological function , now we'll be going to research its application in neonates .Phase 1 Study as a foundation f...
Detailed Description
Previous studies have demonstrated that, carbon monoxide has showed the effectiveness such as in inflammation ,apoptosis as well as relaxation of smooth muscle of the body. Now we have a hypothesis to...
Eligibility Criteria
Inclusion
- The newborn whose physiological function is healthy or close to healthy
Exclusion
- Clinical considerations cannot survive or no treatment value of newborn Diagnosis of congenital or hereditary diseases, or children with heart diseaseCentral pulmonary vascular malformations in children
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT01818843
Start Date
April 1 2012
End Date
December 1 2013
Last Update
March 28 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Daping Hospital
Chongqing, Chongqing Municipality, China, 400042